Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis

Julia Wild,Benjamin J Schmiedel,Andreas Maurer,Stefanie Raab,L. Prokop,Stefan Stevanovic,Daniela Dörfel,Pascal Schneider,Helmut R. Salih

Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis

2015

Julia Wild
Benjamin J Schmiedel
Andreas Maurer
Stefanie Raab
L. Prokop
Stefan Stevanovic
Daniela Dörfel
Pascal Schneider
Helmut R. Salih

Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis

Keywords:

Cancer research
Lymphoma
Rituximab
Belimumab
Cell
Stem cell
B-cell activating factor
Immunology
Leukemia
Haematopoiesis
Biology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations